IP Receptor Polyclonal Antibody

The protein encoded by PTGIR (prostaglandin I2 (prostacyclin) receptor (IP)) is a member of the G-protein coupled receptor family 1 and has been shown to be a receptor for prostacyclin. Prostacyclin, the major product of cyclooxygenase in macrovascular endothelium, elicits a potent vasodilation and inhibition of platelet aggregation through binding to this receptor.

The IP Receptor Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of IP receptors in various biological samples. This antibody is produced using advanced techniques and rigorous quality control measures to ensure optimal performance and reliability.

The IP Receptor Polyclonal Antibody exhibits exceptional affinity and selectivity towards IP receptors, making it an ideal choice for researchers and scientists working in the field of immunology and molecular biology. It has been extensively validated in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

With its superior sensitivity and specificity, the IP Receptor Polyclonal Antibody enables accurate and precise quantification of IP receptor expression levels in different tissues and cell types. It provides valuable insights into the role of IP receptors in various physiological and pathological processes, including inflammation, pain, and cardiovascular diseases.

This antibody is supplied as a ready-to-use solution, ensuring convenience and ease of use. It is compatible with a variety of experimental protocols and can be used in both research and clinical settings. The IP Receptor Polyclonal Antibody is available in different sizes to meet the specific needs of different experiments and applications.

In summary, the IP Receptor Polyclonal Antibody is a reliable and efficient tool for the detection and analysis of IP receptors. Its exceptional sensitivity, specificity, and versatility make it an indispensable asset for researchers and scientists seeking to unravel the complexities of IP receptor signaling pathways and their implications in various biological processes.